XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Shareholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Accumulated
Deficit
Accumulated
Deficit
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Dec. 31, 2020     46,779,479          
Beginning balance at Dec. 31, 2020 $ (123,659) $ (86,433) $ 5 $ 1,222,137 $ (134,450) $ 21 $ (1,345,822) $ 48,017
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (15,749)           (15,749)  
Unrealized gain (loss) from available-for-sale securities (21)         (21)    
Foreign currency gain 0              
Vesting of restricted shares (in shares)     202,018          
Vesting of restricted shares 0              
Exercise of options (in shares)     193,300          
Exercise of options 3,764     3,764        
Issuance of common stock upon purchase by employee stock purchase plan (in shares)     66,301          
Issuance of common stock upon purchase by employee stock purchase plan 678     678        
Share-based compensation expense 5,410     5,410        
Ending balance (in shares) at Mar. 31, 2021     47,241,098          
Ending balance at Mar. 31, 2021 (216,010)   $ 5 1,097,539   0 (1,313,554)  
Beginning balance (in shares) at Dec. 31, 2021     47,359,573          
Beginning balance at Dec. 31, 2021 (252,304)   $ 5 1,115,672   0 (1,367,981)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (18,276)           (18,276)  
Unrealized gain (loss) from available-for-sale securities 0              
Foreign currency gain 6         6    
Vesting of restricted shares (in shares)     139,056          
Vesting of restricted shares 0              
Share-based compensation expense related to share-based awards for employee stock purchase plan 113     113        
Issuance of common stock upon purchase by employee stock purchase plan (in shares)     66,135          
Issuance of common stock upon purchase by employee stock purchase plan 482     482        
Share-based compensation expense 4,032     4,032        
Ending balance (in shares) at Mar. 31, 2022     47,564,764          
Ending balance at Mar. 31, 2022 $ (265,947)   $ 5 $ 1,120,299   $ 6 $ (1,386,257)